Attached files
| file | filename |
|---|---|
| 10-K - 10-K - NEOGENOMICS INC | neo-20201231.htm |
| EX-32.1 - EX-32.1 - NEOGENOMICS INC | neoexhibit32112312020.htm |
| EX-31.2 - EX-31.2 - NEOGENOMICS INC | neoexhibit31212312020.htm |
| EX-31.1 - EX-31.1 - NEOGENOMICS INC | neoexhibit31112312020.htm |
| EX-23.2 - EX-23.2 - NEOGENOMICS INC | neoexhibit23212312020.htm |
| EX-21.1 - EX-21.1 - NEOGENOMICS INC | neoex211listofsubsidiaries.htm |
| EX-10.15 - EX-10.15 - NEOGENOMICS INC | exhibit1015-offerletterd.htm |
| EX-10.14 - EX-10.14 - NEOGENOMICS INC | exhibit1014-employmentag.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-189391, 333-205906, 333-125994, 333-139484, 333-159749, 333-173494, 333-180095, 333-210402 on Form S-8 and Registration Statement Nos. 333-251901, 333-237912, and 333-231608 on Form S-3 of our reports dated February 25, 2021, relating to the consolidated financial statements of NeoGenomics, Inc. and subsidiaries and the effectiveness of NeoGenomics Inc. and subsidiaries’ internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ Deloitte & Touche LLP
San Diego, California
February 25, 2021